LOGIN
Zoledronic Acid, alendronate, and risedronate reduce vertebral, nonvertebral, and hip fracture
October 2018
Zoledronic Acid, alendronate, and risedronate reduce vertebral, nonvertebral, and hip fracture
Study Type:Meta analysis
OE Level Evidence:1
Journal Level of Evidence:N/A
Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses
Osteoporos Int. 2016 Nov;27(11):3289-3300Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
36 randomized controlled trials were included in this network meta-analysis to evaluate the comparative efficacy of different bisphosphonates in the management of osteoporosis. Nine different bisphosphonates were assessed in the included studies, with direct and indirect comparisons evaluated for vertebral fracture, nonvertebral fracture, hip fracture, wrist fracture, and any fracture. Zoledronic ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.